TrialJournal of medical virology2018

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir.

Gretja Schnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.